Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by mediascan59on May 25, 2010 12:11pm
823 Views
Post# 17128870

Comments

CommentsHad a late night here in Vegas and got up to see this. I thought my head hurt before.
Yes, I am disappointed and surprised when I think about all the previous news and indicators released by the company.
I am finding this release confusing, and I don't know if you have been discussing it or not, but we were looking at 4 points as good results and 6 points as excellent results.
We received the 6 points, and that would have made the stock fly except this odd anolomy about the placebo getting 7 points.
Was there not something posted about the body naturally healing itself with aroun 2 points?
This makes me take pause and tells me something has not been reported correctly.

So on one side, the tests tell us our drug works and does not kill anybody. Does this not mean we get to go to Phase 3? I do not believe that having an odd placebo ranking has any effect on this. Was it not a test to see how people react to the drug?

Just throwing this out there because of the oddity of the placebo results.

So, where does that leave SSS trade wise, or better stated, chartwise.

It appears that the stock overreacted to the .08 level and will want to test the .15 level again.
The chart will have the traders jumping in on this level because the charts are just too tempting not too.

There are 2 - 3 weeks of speculation about the findings which will allow the volatility to continue.
It will all depend on what Alan Moore finds out and how a placebo can do miracles, which is what it actually did if you want to believe that number.

I have not sold, as I was willing to wait for the results. I will not sell on this over reaction on a suspect placebo result either and will wait it out for what the company reports.

Obviously not the day I was expecting.

Mediascan
Bullboard Posts